Brain Plus
Brain Plus, licence 80061251: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Canadian Phytopharmaceuticals Corporation
- NPN or DIN-HM
- 80061251
- Status
- Inactive licence
- Licence date
- 27 May 2015
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphatidylsérine Source : Phosphatidylserine | 25.0 milligramme | Not calculated |
| Plectranthus barbatus Source : Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 50.0 milligramme Potency : 20.0 % Forskolin | 5.0 milligramme | Not calculated |
| 5-Oxo-L-proline, composé avec de L-arginine(1:1) Source : Arginine PCA | 62.5 milligramme | Not calculated |
| Beta vulgaris Source : Beta vulgaris - Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 625.0 milligramme Potency : 0.3 % Betanin | 62.5 milligramme | Not calculated |
| (S)-N5-Carbamoylornithine Source : Malate de citrulline | 62.5 milligramme | Not calculated |
| Sulfate de (4-Aminobutyle)guanidinium Source : Sulfate d'agmatine | 62.5 milligramme | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50.0:1.0 Dry plant equivalent : 4000 milligramme Potency : 6.0 % Terpene lactones | 80.0 milligramme | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 24.0 % Flavonoid glycosides | Not specified | Not calculated |
| Cynara cardunculus Source : Feuille Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 500.0 milligramme Potency : 5.0 % Cynarin | 50.0 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 50.0 milligramme | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 3.0 % Rosavin | 144.0 milligramme | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Potency : 1.0 % Salidroside | Not specified | Not calculated |
| Panax ginseng Source : Panax ginseng - racine Potency : 10.0 % Total ginsenosides | 50.0 milligramme | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Potency : 4.0 % Withanolides | 150.0 milligramme | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 1.0 milligramme | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 1.0 milligramme | Not calculated |
| Bacopa monnieri Source : Feuille Extract : Matériel brut sec Extraction ratio : 30.0:1.0 Dry plant equivalent : 2250.0 milligramme Potency : 50.0 % Bacosides A and B | 75.0 milligramme | Not calculated |
| 3-alpha,16-alpha-Apovincaminic acid ethyl ester Source : Vinpocetine | 2.5 milligramme | Not calculated |
| Salvia officinalis Source : Salvia officinalis - Feuille Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 300.0 milligramme | 75.0 milligramme | Not calculated |
| Paullinia cupana Source : Paullinia cupana - Graine Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 100.0 milligramme Potency : 22.0 % Caffeine | 25.0 milligramme | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 37.5 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Acide stéarique, Stéarate de magnésium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation. Provides antioxidants for the maintenance of good health. Used in Herbal Medicine (as an adaptogen) to help to temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness). Used in Herbal Medicine to help support cognitive function (such as mental focus and mental stamina).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80061251
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.